Literature DB >> 10840515

Troglitazone withdrawn from market.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10840515     DOI： 10.1093/ajhp/57.9.834b

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  3 in total

1.  The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects.

Authors:  S L Spinelli; J J O'Brien; S Bancos; G M Lehmann; D L Springer; N Blumberg; C W Francis; M B Taubman; R P Phipps
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

Review 2.  Evolution of the Food and Drug Administration approach to liver safety assessment for new drugs: current status and challenges.

Authors:  John R Senior
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

Review 3.  The CD36-PPARγ Pathway in Metabolic Disorders.

Authors:  Loïze Maréchal; Maximilien Laviolette; Amélie Rodrigue-Way; Baly Sow; Michèle Brochu; Véronique Caron; André Tremblay
Journal:  Int J Mol Sci       Date:  2018-05-21       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.